Literature DB >> 12427239

Methotrexate-induced optic neuropathy.

Chandra Balachandran1, Peter J McCluskey, G David Champion, G Michael Halmagyi.   

Abstract

A 53-year-old Caucasian woman with long-standing, well controlled, severe rheumatoid arthritis, treated with methotrexate, salazopyrin, naprosyn, prednisone and plaquenil, presented with progressive visual loss in each eye. She had a past history of non-necrotizing anterior scleritis that was treated with increased doses of prednisone. She developed left then right central scotomas, reduced vision and optic atrophy. Eventually a diagnosis of methotrexate-induced optic atrophy was made.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427239     DOI: 10.1046/j.1442-9071.2002.00578.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  10 in total

Review 1.  Non-infectious pediatric uveitis: an update on immunomodulatory management.

Authors:  Srilakshmi M Sharma; Andrew D Dick; Athimalaipet V Ramanan
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

Review 2.  Bilateral facial paralysis as a rare neurological manifestation of primary Sjögren's syndrome: case-based review.

Authors:  Zhang Wei; Shi Jiaying; Guo Junhong
Journal:  Rheumatol Int       Date:  2019-06-07       Impact factor: 2.631

Review 3.  Ocular toxicity from systemically administered xenobiotics.

Authors:  Mitan R Gokulgandhi; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-07-18       Impact factor: 4.481

4.  Adalimumab and Non-Arteritic Anterior Ischaemic Optic Neuropathy: A Case Report.

Authors:  Krista Kinard; Jessica A Walsh; Gopi K Penmetsa; Judith E A Warner
Journal:  Neuroophthalmology       Date:  2014-09-10

5.  Methotrexate for ocular inflammatory diseases.

Authors:  Sapna Gangaputra; Craig W Newcomb; Teresa L Liesegang; R Oktay Kaçmaz; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; John H Kempen
Journal:  Ophthalmology       Date:  2009-09-12       Impact factor: 12.079

6.  Resolution of recalcitrant uveitic optic disc edema following administration of methotrexate: two case reports.

Authors:  Se Joon Woo; Mi Jeung Kim; Kyu Hyung Park; Yun Jong Lee; Jeong-Min Hwang
Journal:  Korean J Ophthalmol       Date:  2012-01-14

Review 7.  Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review.

Authors:  Rosanna Dammacco; Silvana Guerriero; Giovanni Alessio; Franco Dammacco
Journal:  Int Ophthalmol       Date:  2021-11-21       Impact factor: 2.029

Review 8.  Potential Ophthalmological Side Effects Induced by Anti-Neoplastic Regimens for the Treatment of Genitourinary Cancers: A Review.

Authors:  Minas Sakellakis; Nikolaos Spathas; Konstantinos T Tsaousis; Emmanouil N Nikitiadis; Helena Linardou; Vasilios F Diakonis
Journal:  Cureus       Date:  2022-07-26

Review 9.  Ocular side effects of antirheumatic medications: a qualitative review.

Authors:  Clara M Castillejo Becerra; Yue Ding; Beatrice Kenol; Andrew Hendershot; Alexa Simon Meara
Journal:  BMJ Open Ophthalmol       Date:  2020-01-07

10.  ABCB1 and ABCG2 Together Limit the Distribution of ABCB1/ABCG2 Substrates to the Human Retina and the ABCG2 Single Nucleotide Polymorphism Q141K (c.421C> A) May Lead to Increased Drug Exposure.

Authors:  Myriam El Biali; Rudolf Karch; Cécile Philippe; Helmuth Haslacher; Nicolas Tournier; Marcus Hacker; Markus Zeitlinger; Doreen Schmidl; Oliver Langer; Martin Bauer
Journal:  Front Pharmacol       Date:  2021-06-16       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.